Daiichi Life Group Inc. offered to buy the remainder of Challenger Ltd. that it doesn’t already own, in a takeover bid that valued the Australian firm at around A$7.9 billion ($5.5 billion).
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.